CC
MACK

Clearline Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Clearline Capital’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-402,176
Closed -$1.22M – 67
2018
Q4 		$1.22M Sell
402,176
-5,631
-1% -$17.1K 0.84% 37
2018
Q3 		$1.71M Buy
407,807
+332,397
+441% +$1.39M 1.01% 31
2018
Q2 		$291K Buy
+75,410
New +$291K 0.19% 49